Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 11/2012

01-11-2012 | Original Article

Advance directives: prevalence and attitudes of cancer patients receiving radiotherapy

Authors: Birgitt van Oorschot, Michael Schuler, Alfred Simon, Michael Flentje

Published in: Supportive Care in Cancer | Issue 11/2012

Login to get access

Abstract

Purpose

Advance directives (AD) are becoming increasingly widespread. We examine the prevalence of AD and the factors associated with AD in tumor patients during radiotherapy.

Methods

A standardized questionnaire was handed out to all tumor patients on 9 random days with an interval of at least 12 weeks. The data were analyzed in a bivariate and multivariate way.

Results

Of 1,208 questionnaires, 658 were completed and returned (54.5%). Of respondents, 23.6% had already signed an AD, 53.3% thought they were likely to sign an AD, 9.0% did not want to sign an AD, and 4.9% were not familiar with advance directives. Patients who have signed an AD and those who are likely to sign one think that ADs facilitate the physician’s decision-making process (97.7% cf. 94.5%) and that they ease the burden on relatives (98.5% cf. 98.8%). Regardless of an AD having been signed, every second respondent was of the opinion that AD facilitates consultations rather than serving as a directive (55.1% cf. 57.3%). Patients likely to sign an AD are significantly younger compared to those unlikely to do so and have suffered from their tumor disease for a shorter period of time.

Conclusions

Of advance directives is widely accepted among the tumor patients surveyed. Advanced directives are not exclusively seen as instruments for surrogate decision making, but also as mediums to improve communication. Training of physicians and additional offers for patients could increase the actual number of ADs and perhaps improve physicians and relatives understanding of patients needs and wishes.
Literature
1.
Deutscher Bundestag (2009) 3. Gesetz zur Änderung des Betreuungsrechts vom 29.07.2009. Bundesgesetzblatt 2009, Teil I Nr. 48, S. 2286–2287
2.
Taupitz J (2010) Das Patientenverfügungsgesetz: Mehr Rechtssicherheit? In: Honnefelder L, Sturma D (ed) Jahrbuch für Wissenschaft und Ethik. Bd 15, De Gruyter, Berlin, pp 175–178
3.
Alano GJ, Pekmezaris R, Tai JY et al (2010) Factors influencing older adults to complete advance directives. Palliat Support Care 8(3):267–275PubMedCrossRef
4.
Kierner KA, Hladschik-Kermer B, Gartner V, Watzke HH (2010) Attitudes of patients with malignancies towards completion of advanced directives. Support Care Cancer 18:367–372CrossRef
5.
Jaspers B, Becker M, King C et al (2010) Ich will nicht so sterben wie mein Vater! Eine qualitative Untersuchung zum Einfluss von Motivationen auf die Konzeption einer Patientenverfügung. Z Palliativmed 11:218–226CrossRef
6.
Lack P (2008) Verschiedene Formen der Patientenverfügung und ihre Eignung für bestimmte Gruppen. Bull Soc Sci Med 3:415–427
7.
Lang FR, Wagner GG (2007) Patient living wills in Germany: conditions for their increase and reasons for refusal. Dtsch Med Wochenschr 132(48):2558–2562PubMedCrossRef
8.
Sahm S, Will R, Hommel G (2005) Attitudes towards and barriers to writing advance directives amongst cancer patients, healthy controls, and medical staff. J Med Ethics 31(8):437–440PubMedCrossRef
9.
van Oorschot B, Hausmann C, Köhler N et al (2004) Patientenverfügung aus Patientensicht. Ergebnisse einer Befragung von palliativ behandelten Tumorpatienten. Ethik Medizin 16:112–122CrossRef
10.
Aday LM, Anderson RM (1974) A framework for the study of access to medical care. Heal Serv Res 9:208–220
11.
Rosnick B, Reynolds S (2003) Thinking ahead: factors associated with executing advanced directives. J Aging Health 15(2):409–429PubMedCrossRef
12.
Rurup ML, Onwuteaka-Philipsen BD, van der Heide A, van der Wal G, Deeg DJ (2006) Frequency and determinants of advance directives concerning end-of-life care in The Netherlands. Soc Sci Med 62(6):1552–1563PubMedCrossRef
13.
van Oorschot B, Simon A (2006) Importance of advance directives and the beginning of the dying process from the point of view of German physicians and judges dealing with guardianship matters: results of an empirical survey. J Med Ethics 32:623–626PubMedCrossRef
14.
Pfirstinger J, Kattner D, Vogelhuber M (2010) Patientenverfügung, Vorsorgevollmacht, betreuungsverfügung bei onkologischen Patienten—wann und durch wen soll eine Beratung erfolgen? Z Palliativmed 11:244CrossRef
15.
Scholer-Evertz R, Klaschik E, Eibach U (2002) Patientenautonomie und Patientenverfügung: Ergebnisse einer Befragung bei stationären Palliativpatienten. Z Palliativmed 3:77–84CrossRef
16.
Teno J, Lynn J, Wenger N et al (1997) Advance directives for seriously ill hospitalized patients: effectiveness with the patient self-determination act and the SUPPORT intervention. SUPPORT Investigators. Study to understand prognoses and preferences for outcomes and risks of treatment. J Am Geriatr Soc 45(4):500–507PubMed
17.
Dow LA, Matsuyama RK, Ramakrishnan V et al (2009) Paradoxes in advance care planning: the complex relationship of oncology patients, their physicians, and advance medical directives. J Clin Oncol 28(2):299–304PubMedCrossRef
18.
Ozanne EM, Partridge A, Moy B et al (2009) Doctor–patient communication about advance directives in metastatic breast cancer. J Palliat Med 12(6):547–553PubMedCrossRef
19.
Bradley NM, Sinclair E, Danjoux C et al (2006) The do-not-resuscitate order: incidence of documentation in the medical records of cancer patients referred for palliative radiotherapy. Curr Oncol 13(2):47–54PubMed
20.
Sahm S, Will R, Hommel G (2005) Would they follow what has been laid down? Cancer patients’ and healthy controls’ views on adherence to advance directives compared to medical staff. Med Health Care Philos 8(3):297–305PubMedCrossRef
21.
Nishimura A, Mueller PS, Evenson LK et al (2007) Patients who complete advance directives and what they prefer. Mayo Clin Proc 82(12):1480–1486PubMedCrossRef
22.
Schröder C, Schmutzer G, Brähler E (2002) Repräsentativbefragung der deutschen Bevölkerung zu Aufklärungswunsch und Patientenverfügung bei unheilbarer Krankheit. Psychother Psychosomat Med Psychol 52(5):236–243CrossRef
23.
24.
Sehgal A (1996) Advance directives and withdrawal of dialysis in the United States, Germany and Italy. JAMA 276(20):1652–1656PubMedCrossRef
25.
Anselm R (2008) Wir müssen darüber reden—Patientenverfügungen als Kommunikationsinstrumente. Ethik in der Medizin 3:191–200CrossRef
26.
Müller-Busch C (2010) Ärztliche Entscheidungen in Grenzsituationen. Patientenverfügungen als Instrumente des Dialogs. In: Honnefelder L, Sturma D (ed) Jahrbuch für Wissenschaft und Ethik. Bd 15, De Gruyter, Berlin, pp 193–210
27.
De Haes H (2006) Dilemmas in patient centeredness and shared decision making: a case for vulnerability. Patient Educ Counsel 62:291–298CrossRef
28.
Schicktanz S (2008) Zwischen Selbstdeutung und Interpretation durch Dritte: Zum Wechselverhältnis von soziokulturellen und ethischen Aspekten von Patientenverfügungen. Ethik in der Medizin 3:181–190CrossRef
29.
Sahm S, Will R, Hommel G (2005) What are cancer patients’ preferences about treatment at the end of life, and who should start talking about it? A comparison with healthy people and medical staff. Support Care Canc 13(4):206–214CrossRef
30.
Becker M, Jaspers B, King C et al (2010) Did you seek assistance for writing your advance directive? A qualitative study. Wien Klin Wochenschr 122(21–22):620–625PubMedCrossRef
31.
Barnes KA, Barlow CA, Harrington J et al (2011) Advance care planning discussions in advanced cancer: analysis of dialogues between patients and care planning mediators. Palliat Support Care 9:73–79PubMedCrossRef
32.
Prommer EE (2010) Using the values-based history to fine-tune advance care planning for oncology patients. J Cancer Educ 25(1):66–69PubMedCrossRef
33.
Tulsky JA (2005) Beyond advance directives: importance of communication skills at the end of life. JAMA 20;294(3):359–365CrossRef
34.
Wiese C, Bartels U, Geyer A et al (2008) Göttinger Palliativkrisenbogen: Verbesserung der notfallmäßigen Versorgung von Palliativpatienten. Dtsch Med Wochenschr 133:972–976PubMedCrossRef
35.
Jones L, Harrington J, Barlow CA et al (2011) Advance care planning in advanced cancer: can it be achieved? An exploratory randomized patient preference trial of a care planning discussion. Palliat Support Care 9(1):3–13PubMedCrossRef
36.
Pautex S, Notaridis G, Déramé L, Zulian GB (2010) Preferences of elderly cancer patients in their advance directives. Crit Rev Oncol Hematol 74(1):61–65PubMedCrossRef
37.
Ditto PH, Danks JH, Smucker WD et al (2001) Advance directives as acts of communication: a randomized controlled trial. Arch Intern Med 161(3):421–430PubMedCrossRef
Metadata
Title
Advance directives: prevalence and attitudes of cancer patients receiving radiotherapy
Authors
Birgitt van Oorschot
Michael Schuler
Alfred Simon
Michael Flentje
Publication date
01-11-2012
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 11/2012
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-012-1394-y

Other articles of this Issue 11/2012

Supportive Care in Cancer 11/2012 Go to the issue

Short Communication

High incidence of bloodstream infection detected by surveillance blood cultures in hematology patients on corticosteroid therapy

Original Article

Surrender as a form of active acceptance among breast cancer survivors receiving Psycho-Spiritual Integrative Therapy

Original Article

Implementing patient-centred cancer care: using experience-based co-design to improve patient experience in breast and lung cancer services

Short Communication

Successful treatment of intractable hiccups by oral application of lidocaine

Original Article

Dietary energy density is associated with energy intake in palliative care cancer patients

Original Article

Prospective observational Italian study on palliative sedation in two hospice settings: differences in casemixes and clinical care
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits